CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells.

Akhtar, Javed; Imran, Muhammad; Wang, Guanyu

Akhtar, Javed; Imran, Muhammad; Wang, Guanyu.

Afiliação

Akhtar J; Futian Biomedical Innovation R&D Center, The Chinese University of Hong Kong, Shenzhen 518172, China.
Imran M; Biomedical Science and Engineering, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
Wang G; Ciechanover Institute of Precision and Regenerative Medicine, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.

Int J Mol Sci ; 24(18)2023 Sep 13.

Article em En | MEDLINE | ID: mdl-37762332

Palavras-chave

C-Terminal Binding Protein 1 (CtBP1); CRISPR/Cas9 genome editing; esophageal squamous cell carcinoma (ESCC); paclitaxel resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article